SCHEMBL10245554

SCHEMBL10245554

O=[N+](O)/C=C/c1ccc(COc2ccccn2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.46
ALDH1A1 P00352 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C19 P33261 1/20 0.46
TLR4 O00206 7/20 0.41
TLR2 O60603 7/20 0.41
GSK3B P49841 2/20 0.38
BACE1 P56817 2/20 0.38
MAOA P21397 4/20 0.38
MAOB P27338 4/20 0.38
PPARG P37231 1/20 0.36
PPARA Q07869 1/20 0.36
CYP1A1 P04798 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP19A1 P11511 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
GABRA5 P31644 1/20 0.35
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL510291 0.86 TLR4 (0.56) NPC1ALDH1A1CYP2D6CYP2C19TLR4
SCHEMBL510290 0.86 TLR4 (0.56) NPC1ALDH1A1CYP2D6CYP2C19TLR4
SCHEMBL10245208 0.82 TLR4 (0.44) TLR4TLR2GSK3BBACE1MAOA
SCHEMBL1106855 0.81 MAOA (0.41) NPC1TLR4TLR2MAOAMAOB
SCHEMBL13513283 0.79 ALDH1A1 (0.51) NPC1ALDH1A1CYP2D6CYP2C19GSK3B
SCHEMBL510142 0.78 ALDH1A1 (0.54) NPC1ALDH1A1CYP2D6CYP2C19MAOA
SCHEMBL10245518 0.77 GSK3B (0.62) NPC1ALDH1A1CYP2C19TLR4TLR2
SCHEMBL10055039 0.77 NPC1 (0.68) NPC1ALDH1A1CYP2D6CYP2C19CYP1A2
SCHEMBL10246548 0.76 NPC1 (0.49) NPC1ALDH1A1CYP2D6CYP2C19MEN1
SCHEMBL13784430 0.75 ALDH1A1 (0.54) NPC1ALDH1A1CYP2D6CYP2C19PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8841327-B2 Heterocycles substituted pyridine derivatives and antifungal agent containing thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2014-09-23 US disclosed
EP-2223926-B1 PYRIDINE DERIVATIVE SUBSTITUTED WITH HETEROCYCLE AND PHOSPHONOXYMETHYL GROUP AND ANTIFUNGAL AGENT CONTAINING THE SAME EISAI R&D MAN CO LTD (JP) 2014-02-12 EP disclosed
US-20120029023-A1 HETEROCYCLES SUBSTITUTED PYRIDINE DERIVATIVES AND ANTIFUNGAL AGENT CONTAINING THEREOF TANAKA KEIGO (JP) 2012-02-02 US disclosed
EP-2223926-A1 PYRIDINE DERIVATIVE SUBSTITUTED WITH HETEROCYCLE AND PHOSPHONOXYMETHYL GROUP AND ANTIFUNGAL AGENT CONTAINING THE SAME Eisai R&D Management Co., Ltd. (JP) 2010-09-01 EP disclosed
WO-2009084621-A1 PYRIDINE DERIVATIVE SUBSTITUTED WITH HETEROCYCLE AND PHOSPHONOXYMETHYL GROUP AND ANTIFUNGAL AGENT CONTAINING THE SAME EISAI R & D MANAGEMENT CO., LTD. (JP) 2009-07-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120029023-A1 HETEROCYCLES SUBSTITUTED PYRIDINE DERIVATIVES AND ANTIFUNGAL AGENT CONTAINING THEREOF CYP4X1, ERG28, CYP51A1 NPC1 733/4885ALDH1A1 770/4885CYP2D6 39/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.